Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
Because of scepticism concerning study results when relying solely on relative effect estimates, the number needed to treat (NNT) has been used extensively to quantify the net clinical benefit of an intervention, and is reported increasingly in randomised trials and observational studies. This metho...
Main Authors: | Annie C. Lajoie, Sébastien Bonnet, Yves Lacasse, Jean-Christophe Lega, Steeve Provencher |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-05-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/27/148/180020.full |
Similar Items
-
Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
by: Charles-Antoine Guay, et al.
Published: (2018-01-01) -
Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries
by: Steeve Provencher, et al.
Published: (2024-03-01) -
Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
by: Simon Malenfant, et al.
Published: (2020-03-01) -
Alternatives to the six-minute walk test in pulmonary arterial hypertension.
by: Vincent Mainguy, et al.
Published: (2014-01-01) -
Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
by: Sarah-Eve Lemay, et al.
Published: (2021-06-01)